Hybrid cyclic libraries and screens thereof
AssigneeThe Johns Hopkins University
InventorsJun O. Liu, Jingxin Wang, Zufeng Guo, Wei Li, Shridhar Bhat, Manisha Das
Life of this patent
Estimating the term…
Abstract
Provided are novel types of hybrid cyclic libraries that contain a known protein binding domain of a natural product. Also provided are synthetic methods to make such libraries and methods for the deconvolution of hits using partially split-pooled library compounds. Such methods are applicable for use with the entire human proteome to screen such libraries that bind and for the identification of hits.
Claims20
A macrocyclic compound comprising:
- an immunophilin-binding domain selected from the group consisting of a FK506-binding protein (FKBP)-binding domain (FKBD) and a cyclosporin-binding cyclophilins (CyP)-binding domain;
- an effector domain comprising a heteroatom configured to bind a target protein;
- and
- a linker moiety connecting the immunophilin-binding domain and the effector domain.
A method of identifying a macrocyclic compound comprising:
- (a) contacting the macrocyclic compound with a target protein in the presence of an immunophilin, wherein the macrocyclic compound comprises an immunophilin-binding domain selected from the group consisting of a FK506-binding protein (FKBP)-binding domain (FKBD) and a cyclosporin-binding cyclophilins (CyP)-binding domain, an effector domain comprising a polypeptide, and a linker moiety;
- (b) detecting the presence of a ternary complex comprising the macrocyclic compound, the immunophilin, and the target protein;
- thereby identifying the macrocyclic compound.
A method of determining the function a protein comprising:
- (a) contacting a library of macrocyclic compounds with the protein encoded by genes in a genome in the presence of an immunophilin, wherein the macrocyclic compound comprises an immunophilin-binding domain selected from the group consisting of a FK506-binding protein (FKBP)-binding domain (FKBD) and a cyclosporin-binding cyclophilins (CyP)-binding domain, an effector domain comprising a polypeptide, and a linker moiety;
- (b) detecting the presence of a ternary complex comprising the macrocyclic compound, the immunophilin and the protein;
- (c) identifying the protein in the ternary complex;
- and
- (d) determining the function of the protein based on a perturbed chemical and/or cellular function.
Dependencies are inferred from the claim text.